Pricing Log in Create free account

Immunome, Inc. (IMNM) vs Vera Therapeutics, Inc. (VERA)

Immunome, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Immunome, Inc. and Vera Therapeutics, Inc. are of similar size ($2.2B and $2.1B). Across the 11 metrics below, Immunome, Inc. leads on 9 and Vera Therapeutics, Inc. on 2.

Valuation

Metric IMNM VERA Biotechnology median
P/E n/m n/m 10.26
P/S 162.50 n/m 9.18
P/B 3.90 5.34 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 121.23 n/m 8.98
Earnings yield (14.01%) (19.32%) (34.89%)
Free cash flow yield (10.71%) (15.55%) (24.52%)

Profitability

Metric IMNM VERA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.03%) (91.75%) (50.12%)
Return on assets (59.03%) (72.32%) (45.60%)
Return on invested capital (3,322.99%) 0.00% 0.00%

Growth

Metric IMNM VERA Biotechnology median
Revenue growth (TTM) 16.74% — 6.26%
EPS growth (last fiscal year) 51.40% (69.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMNM VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 15.08 10.92 4.89
Net debt to EBITDA 2.92 2.00 1.01

Dividend

Metric IMNM VERA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMNM VERA Biotechnology median
Market cap 2.11b 2.17b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack